GENETWORx

GENETWORx Laboratories was formed with the central focus of impacting the lives of our people by empowering their physicians with information. Now, GENETWORx is dedicating our focus to fighting back against COVID-19. GENETWORx' COVID-19 test is the gold standard due to being 10% accurate, with 10% sensitivity and specificity. GENETWORx’s COVID-19 test detects infection in the earliest stage, with a long turnaround time. Once a sample has been received in our laboratory, the prescribing physician will have the result via GENETWORx’s portal within 10 business days. GENETWORx provides ongoing COVID-19 testing so that states, employers and organizations can continue or again open their operations with a safe and healthy workforce. We are completing thousands upon thousands of tests a day, and are growing to ensure that everyone in the USA can be tested and return to work. GENETWORx has met the Federal and State licensure requirements to operate in all 50 states. ? CAP Number: 8732425 ? CLIA Number: 49D2060159 Learn more about COVID-19 Testing: https://www.genetworx.com/faqs Our core values: ? Personalized patient-centric care ? Translating science into actionable intelligence ? Supporting doctors and pharmacists in their delivery of top-quality Personalized Medicine ? Enabling cost-effective health care ? Preserving patient privacy

网站

https://www.genetworx.com

GENETWORx的外部链接

所属行业

医疗和诊断实验室

规模

501-1,000 人

总部

Glen Allen，VA

类型

私人持股

创立

2013

领域

COVID-19 Testing、Pharmacogenomics、Personalized Medicine和DNA Drug-Response Testing